Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas.

Source:http://linkedlifedata.com/resource/pubmed/id/3888429

Download in:

View as

General Info

PMID
3888429